467P HERV-K as a shared tumor antigen in non-small cell lung cancer (NSCLC): Rationale for immunotherapy and checkpoint blockade combination

Authors: M. Perez-Penco, L. Neukirch, M.D. Müller et al.
Publication: ESMO Open
Published: Apr 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Government intervention or market incentives: which more effectively accelerates enterprise IT adoption in accounting systems? evidence from China’s financial shared service centers

Yuan Qian - Dec 2026

Read More
Assessing the demand for shared micromobility systems on university campuses in Ghana

Jeff Kojo Nathan, Emmanuel Dzisi - Dec 2026

Read More
Toward shared situational awareness in human-AI hybrid intelligence: A survey in high-risk aviation environments

Donglin Li, Mingrui Li et al. - Oct 2026

Read More
Beyond the inbox: Exploring shared cognitive mechanisms underlying susceptibility to and reporting of deception across digital domains

Katharine E. Sabo, Dawn M. Sarno et al. - Sep 2026

Read More
Josephson Arbitrary Waveform Synthesizer for Flux-Ramp Modulation in Microwave SQUID Multiplexers

Matías Hampel, Luciano Ferreyro et al. - Sep 2026

Read More